openPR Logo
Press release

Rising Autoimmune Disease Prevalence Fuels Market Growth: A Key Factor Shaping the Future of the Talvey Market in 2025

03-28-2025 03:44 PM CET | Health & Medicine

Press release from: The Business Research Company

Talvey

Talvey

Get 20% off on all our 2025 Global Market Reports with code FY25SAVE - Offer valid till March 31st! What industry-specific factors are fueling the growth of the talvey market?
The rising prevalence of autoimmune diseases is expected to drive the growth of the Talvey market going forward. Autoimmune diseases occur when the immune system mistakenly attacks the body's own tissues, often triggered by factors such as genetic predisposition, environmental influences, and lifestyle changes. As the frequency of autoimmune disorders continues to rise, Talvey (natalizumab-sztn), a medication that targets and blocks integrins, is becoming increasingly crucial. By preventing immune cells from crossing into the central nervous system, Talvey helps reduce inflammation associated with autoimmune conditions like multiple sclerosis and Crohn's disease. For example, a systematic review in August 2022 highlighted the rising incidence of autoimmune diseases, with 81.5% of cases newly emerging post-COVID vaccination. Therefore, the increasing prevalence of autoimmune diseases is a significant driver for the growth of the Talvey market.

Get Your Talvey Market Report Here:
https://www.thebusinessresearchcompany.com/report/talvey-global-market-report

What Is the projected market size and growth rate for the talvey market?
The talvey market size has expanded at XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth is attributed to the rising demand for outpatient and home care solutions, supportive insurance and reimbursement policies, increased investments in biotechnology, improved patient adherence programs, and the growing number of clinical trials.

The Talvey market size is expected to see XX% FCAGR in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising prevalence of autoimmune diseases, the aging population, increasing healthcare expenditure, a focus on personalized medicine, and government support and incentives. Major trends include improvements in bioavailability, combination therapy, demand for targeted therapies, demand for non-invasive treatments, and innovations in drug formulations.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20309&type=smp

What new trends are reshaping the talvey market and its opportunities?
A prevailing trend in the talvey market is securing drug sanction from regulatory bodies to stay competitive. This approval procedure implies that a new pharmaceutical product has been scrutinized for its safety, effectiveness, and quality based on evidence from clinical trials, and is now authorized for sale and use. An example occurred in August 2023, when Johnson & Johnson's Janssen Pharmaceutical Companies, based in the US, proclaimed obtaining approval from the U.S. Food and Drug Administration (FDA) for TALVEY (talquetamab-tgvs). This pioneering bispecific antibody serves adult patients suffering from relapsed or refractory multiple myeloma who have undergone at least four lines of treatment including immunomodulatory drugs, anti-CD38 antibodies, and proteasome inhibitors. TALVEY, as a bispecific T-cell-engaging antibody, targets the CD3 receptor located on T cells, and GPRC5D found on multiple myeloma cells, nonmalignant plasma cells, and keratinized tissues. Due to its response rate and durability, TALVEY gained accelerated approval and can be administered in the form of weekly or biweekly subcutaneous injections after a phase-in period, providing a flexible dosage regime.

What major market segments define the scope and growth of the talvey market?
The talvey market covered in this report is segmented -

1) By Formulation: 3mg Or 1.5ml; 40mg Or ml
2) By Clinical Indication: Relapsed Or Refractory Multiple Myeloma; Monotherapy Treatment
3) By Distribution Channel: Hospital Pharmacies; Specialty Pharmacies; Online Pharmacies
4) By End User: Adult; Geriatric

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20309

Which region dominates the talvey market?
North America was the largest region in the talvey market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the talvey market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the talvey industry growth?
Major companies operating in the talvey market are Johnson & Johnson

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20309&type=smp

What Is Covered In The Talvey Global Market Report?

•Market Size Forecast: Examine the talvey market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the talvey market for a structured understanding.
•Key Players Overview: Analyze major players in the talvey market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the talvey market.
•Segment Contributions: Evaluate how different segments drive overall growth in the talvey market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the talvey market.
•Industry Challenges: Identify potential risks and obstacles affecting the talvey market.
•Competitive Landscape: Review strategic developments in the talvey market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Autoimmune Disease Prevalence Fuels Market Growth: A Key Factor Shaping the Future of the Talvey Market in 2025 here

News-ID: 3945527 • Views:

More Releases from The Business Research Company

Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 Billion By 2030 At 12.2% CAGR
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory. Projected Growth and Market Size of
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030. Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook Through 2030
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future. Pediatric Orthopedic Implants Market Size and
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Segments And Regional Growth
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes. Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market The market for pediatric interventional cardiology is forecasted to grow steadily,

All 5 Releases


More Releases for Talvey

Segmentation, Major Trends, and Competitive Overview of the T Cell Surface Glyco …
The T Cell Surface Glycoprotein CD3 Epsilon Chain market is emerging as a vital sector within biotechnology and pharmaceutical research, driven by scientific advancements and growing therapeutic applications. This overview explores the market's projected growth, influential trends, major industry players, and its segmentation to provide a comprehensive understanding of its future trajectory. Projected Market Growth and Size of the T Cell Surface Glycoprotein CD3 Epsilon Chain Industry The market for
Multiple Myeloma Market Size (7MM) was estimated to be nearly USD 21,300 million …
DelveInsight's "Multiple Myeloma Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of multiple myeloma, historical and forecasted epidemiology as well as Multiple Myeloma therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Discover more about the multiple myeloma market in detail @ Multiple Myeloma Market Report- https://www.delveinsight.com/sample-request/multiple-myeloma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Multiple Myeloma Market Report • In September
New Growth Trends Accelerating Expansion In The Cluster Of Differentiation 3 (CD …
The cluster of differentiation 3 (CD3) antibody market is on the brink of significant expansion, driven by advancements in immunotherapy and growing demand for targeted cancer treatments. This market is expected to experience rapid growth as new technologies and increasing healthcare investments pave the way for innovative therapies. Below, we explore the market size, key players, trends, and segmentation shaping the CD3 antibody landscape through 2029. Projected Growth and Size of
Global Bispecifics/Trispecifics Market Outlook 2025-2035: DelveInsight Forecasts …
(Albany, USA) - September 18, 2025 - According to DelveInsight's latest report, "Bispecifics/Trispecifics Market Size, Target Population, Competitive Landscape, and Market Forecast - 2035", the global market for bispecific and trispecific antibodies is expected to grow significantly between 2025 and 2035, driven by rising demand for advanced immunotherapies, increased R&D investments, and a rapidly expanding patient pool across cancer and autoimmune indications. Download DelveInsight's Bispecifics/Trispecifics Market Report to explore forecasts, pipelines,
Talvey Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunitie …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Projected Growth of the Talvey Market? The size of the talvey market has exhibited an XX (HCAGR) growth trend in the past few years. The market's expansion is projected to continue, growing from a valuation of $XX million in 2024 to $XX million in 2025, achieving a compound annual
Leading Element Driving Change in the Talvey Market in 2025: Rising Autoimmune D …
What Is the Expected Size and Growth Rate of the Talvey Market? The size of the talvey market, which has achieved an $XX% CAGR in recent years, is predicted to expand from $XX million in 2024 to $XX million in 2025, at a CAGR of $XX%. The considerable growth during the historic period is a result of increasing demand for outpatient and home care options, supportive insurance and reimbursement strategies, escalated